Will December 24 Be The Bottom For Marijuana Stocks? Will December 24 Be The Bottom For Marijuana Stocks?
Marijuana Stocks, Finance, & Investing November 28, 2018 0
Will December 24 Be The Bottom For Marijuana Stocks?
The sell-off in marijuana stocks has been relentless, but the bottom could be getting close.
Organigram becomes an official supplier of cannabis in the Province of Saskatchewan Organigram becomes an official supplier of cannabis in the Province of Saskatchewan
Marijuana Stocks, Finance, & Investing November 28, 2018 0
Organigram becomes an official supplier of cannabis in the Province of Saskatchewan
Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc., a leading licensed producer of cannabis, is pleased announce it has completed the registration process with Saskatchewan Liquor and Gaming Authority (SLGA), making it an official supplier of cannabis for the province.
Aurora Cannabis to Ship Medical Cannabis to the Czech Republic Aurora Cannabis to Ship Medical Cannabis to the Czech Republic
Marijuana Stocks, Finance, & Investing November 28, 2018 0
Aurora Cannabis to Ship Medical Cannabis to the Czech Republic
Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that the company has received an export request, has secured the required export permit and has now completed its first shipment of medical cannabis products to the Czech Republic, making this the 21st country in which the company operates.
Battelle and Canopy Growth Announce Strategic Collaboration to Advance Cannabis Research Battelle and Canopy Growth Announce Strategic Collaboration to Advance Cannabis Research
Marijuana Stocks, Finance, & Investing November 28, 2018 0
Battelle and Canopy Growth Announce Strategic Collaboration to Advance Cannabis Research
Battelle, the world’s largest nonprofit research and development organization, and Canopy Growth Corporation (TSX: WEED) (NYSE: CGC), the world’s largest diversified cannabis company, today announced the completion of multiple fully legal cannabis imports from Canada to the United States.
Curaleaf Earnings Reports Exemplifies Current Marijuana Stock Conundrum Curaleaf Earnings Reports Exemplifies Current Marijuana Stock Conundrum
Marijuana Stocks, Finance, & Investing November 28, 2018 0
Curaleaf Earnings Reports Exemplifies Current Marijuana Stock Conundrum
Curaleaf is one of the rising stars of the U.S. marijuana industry, but its latest earnings report should…
Grown Rogue to Commence Trading on the Canadian Securities Exchange Grown Rogue to Commence Trading on the Canadian Securities Exchange
Marijuana Stocks, Finance, & Investing November 26, 2018 0
Grown Rogue to Commence Trading on the Canadian Securities Exchange
Grown Rogue International Inc. (CSE:GRIN) a seed-to-experience cannabis brand announces that the Company’s common shares are scheduled to commence trading today on the Canadian Securities Exchange under the ticker symbol “GRIN”.
GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for EPIDIOLEX® (cannabidiol) oral solution CV in Patients with Dravet Syndrome GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for EPIDIOLEX® (cannabidiol) oral solution CV in Patients with Dravet Syndrome
Marijuana Stocks, Finance, & Investing November 26, 2018 0
GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for EPIDIOLEX® (cannabidiol) oral solution CV in Patients with Dravet Syndrome
GW Pharmaceuticals plc (Nasdaq: GWPH), announces positive top-line results of the second randomized, double-blind, placebo-controlled Phase 3 clinical trial of EPIDIOLEX® (cannabidiol or CBD) CV in the treatment of seizures associated with Dravet syndrome, a rare and severe form of childhood-onset epilepsy.
Wayland Group Enters the United Kingdom Wayland Group Enters the United Kingdom
Marijuana Stocks, Finance, & Investing November 26, 2018 0
Wayland Group Enters the United Kingdom
Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) is pleased to announce it has entered into an agreement to acquire 51% of UK based Theros Pharma Ltd., an early stage company that has successfully imported cannabis to the UK for patients with a prescription for medical cannabis.
Canopy Rivers Secures International Joint Venture Rights and Accelerates Development at PharmHouse "/>
Canopy Rivers Secures International Joint Venture Rights and Accelerates Development at PharmHouse
Marijuana Stocks, Finance, & Investing November 23, 2018 0
Canopy Rivers Secures International Joint Venture Rights and Accelerates Development at PharmHouse
Under the terms of the agreement, the Company will provide up to C$40 million of secured debt financing with a three-year term and an annual interest rate of 12%, calculated monthly and payable quarterly after receipt of the sales license at PharmHouse’s initial production and processing facility.
